XML 58 R38.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCKHOLDERS' EQUITY (Tables)
 12 Months Ended
Dec. 31, 2023
Stockholders' Equity Note [Abstract]  
Schedule of Compensation Cost on Net Earnings
The Company’s results for the years ended December 31, 2023, 2022 and 2021 reflected the following compensation cost and such compensation cost had the following effects on net earnings:
 Increase/(Decrease) for the
Year Ended December 31,
 202320222021
Cost of sales$1,900 $1,302 $845 
Operating expenses14,152 11,922 9,957 
Net earnings(12,375)(10,214)(8,370)
Schedule of Assumptions Used in the Valuation of Option Awards Risk-free interest rates are based on the implied yields currently available on U.S. Treasury zero coupon issues with a remaining term equal to the expected life.
Year Ended December 31,
Weighted Average Assumptions:202320222021
Expected Volatility28.1 %30.3 %32.9 %
Expected Term (in years)4.87.34.9
Risk-Free Interest Rate3.9 %2.8 %0.5 %
Dividend Yield0.5 %0.5 %0.5 %
Summary of Stock Option Activity
A summary of stock option plan activity for 2023, 2022, and 2021 for all plans is as follows:
202320222021
# of
Shares
(000s)		Weighted Average
Exercise Price		# of
Shares
(000s)		Weighted Average
Exercise Price		# of
Shares
(000s)		Weighted Average
Exercise Price
Outstanding at beginning of year1,045 $99.82 867 $88.19 858 $80.58 
Granted109 138.09 239 139.04 129 119.12 
Exercised(64)81.98 (44)73.58 (109)63.42 
Forfeited(11)131.79 (17)124.89 (10)106.93 
Cancelled(1)138.07 — — (1)74.57 
Outstanding at end of year1,078 $104.38 1,045 $99.82 867 $88.19 
Exercisable at end of year720 $88.49 654 $81.95 538 $75.51 
Schedule of Other Information Pertaining to Stock Option Activity
Other information pertaining to option activity during the years ended December 31, 2023, 2022 and 2021 is as follows:

 Years Ended December 31,
 202320222021
Weighted-average fair value of options granted$40.91 $44.77 $33.11 
Total intrinsic value of stock options exercised ($000s)$3,241 $2,713 $7,866 
Schedule of Additional Information Relating to Stock Options Outstanding
Additional information related to stock options outstanding under all plans at December 31, 2023 is as follows:

  Options OutstandingOptions Exercisable
Range of Exercise
Prices		Shares
Outstanding
(000s)		Weighted
Average
Remaining
Contractual
 Term		Weighted
Average
 Exercise
Price		Number
Exercisable
(000s)		Weighted
Average
Exercise
Price
$54.87 - $85.33
387 3.5$72.41 387 $72.41 
$85.40 - $118.60
250 4.9101.84 248 101.71 
$118.96 - $150.85
441 8.1133.93 85 123.47 
 1,078 5.7$104.38 720 $88.49 
Schedule of Non-vested Restricted Stock Activity
Non-vested restricted stock activity for the years ended December 31, 2023, 2022 and 2021 is summarized below:
202320222021
 Shares (000s)Weighted
Average Grant
Date Fair
Value		Shares (000s)Weighted
Average Grant
Date Fair
Value		Shares (000s)Weighted
Average Grant
Date Fair
Value
Non-vested balance at beginning of year 122 $124.42 166 $99.7 159 $90.71 
Granted40 137.20 46 137.17 42 123.58 
Vested(42)112.30 (82)82.15 (24)85.83 
Forfeited(4)128.06 (8)118.07 (11)90.49 
Non-vested balance at end of year 116 $133.06 122 $124.42 166 $99.7 
Schedule of Non-vested Performance Share Activity
Non-vested performance share activity for the years ended December 31, 2023, 2022 and 2021 is summarized below:

202320222021
 Shares (000s)Weighted
Average Grant
Date Fair
Value		Shares (000s)Weighted
Average Grant
Date Fair
Value		Shares (000s)Weighted
Average Grant
Date Fair
Value
Non-vested balance at beginning of year 70 $127.69 69 $110.72 71 $91.99 
Granted42 139.66 39 114.22 36 108.74 
Vested(36)98.84 (35)53.17 (24)70.64 
Forfeited— — (3)84.09 (14)81.03 
Non-vested balance at end of year 76 $135.25 70 $127.69 69 $110.72